Search

Copyright of China Sciencepaper is the property of China Sciencepaper and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Shandong Medical Journal is the property of Shandong Medical Health Newspapers and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

OBJECTIVE: To investigate the application status of antihypertensive drugs in Peking University International Hospital (hereinafter referred to as “our hospital”) in the past 3 years, so as to provide reference for drug administration. METHODS: Defined daily dose method was adopted, and retrospectively statistical analysis was conducted on consumption sum, defined daily dose system(DDDs) and defined daily dose cost(DDC) during 2015-2017. RESULTS: During 2015-2017, the consumption sum of of oral antihypertensive drugs in our hospital had increased rapidly, from 240 600 yuan in 2015 to 4 182 100 yuan in 2017. The top 2 drugs ranked by consumption sum and DDDs were respectively calcium channel blocker, angiotensin II receptor blocker; the consumption sum and DDDs of angiotensin-converting enzyme inhibitors increased slowly, and the consumption sum and DDDs of compound preparations was in an increasing trend. Among the calcium channel blockers, the consumption sum and DDDs of the imported drugs of Amlodipine besylale tablets (LuoHuoXi) and Nifedipine controlled release tablets (BaiXinTong) dominated the top two places. Among the angiotensin II receptor blockers, the consumption sum and DDDs of the imported drugs of Losartan potassium tablets(KeSuYa) took the lead. Other types of oral antihypertensive drugs still took the proportion due to the unique antihypertensive characteristics, but the proportion of consumption sum was < 20%. CONCLUSIONS: The application of oral antihypertensive drugs in our hospital is in line with the current drug development trends and guidelines for selection. [ABSTRACT FROM AUTHOR]

Copyright of Chinese Journal of Oncology is the property of Chinese Journal of Oncology / Zhonghua Zhongliu Zazhi and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi is the property of Journal of Clinical Hepatology and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)